首页> 外文会议>American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics >Validation of a Method for the Determination of Lapatinib in Human Plasma by LC-MS/MS
【24h】

Validation of a Method for the Determination of Lapatinib in Human Plasma by LC-MS/MS

机译:通过LC-MS / MS验证Lapatinib测定Lapatinib的方法

获取原文

摘要

Lapatinib functions as an inhibitor to the EGFR and erbB-2 receptors. These specific receptors are part of the Type I receptor kinase family involved in cell proliferation. Because cells with inactive Type I receptors don't exhibit uncontrolled growth, it is believed that an inhibitor of erbB kinases could be useful in inhibiting uncontrolled cell growth via stasis or cell death. Presented here is the validation of an LC/MS/MS assay for lapatinib in human plasma.
机译:Lapatinib用作EGFR和ERBB-2受体的抑制剂。这些特异性受体是参与细胞增殖的I型受体激酶系列的一部分。因为具有非活性I型受体的细胞不会出现不受控制的生长,所以认为ERBB激酶的抑制剂可用于通过瘀滞或细胞死亡抑制不受控制的细胞生长。这里介绍的是验证Lapatinib在人血浆中的LC / MS / MS测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号